Signalling pathways regulating muscle mass in ageing skeletal muscle. The role of the IGF1-Akt-mTOR-FoxO pathway

[1]  S. Schiaffino,et al.  Role of satellite cells in muscle growth and maintenance of muscle mass. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[2]  M. Sandri,et al.  Mechanisms regulating skeletal muscle growth and atrophy , 2013, The FEBS journal.

[3]  Roberto Bottinelli,et al.  The time course of the adaptations of human muscle proteome to bed rest and the underlying mechanisms , 2012, The Journal of physiology.

[4]  Peter M. Douglas,et al.  RPN-6 determines C. elegans longevity under proteotoxic stress conditions , 2012, Nature.

[5]  Eric Ravussin,et al.  Skeletal Muscle Mitochondria and Aging: A Review , 2012, Journal of aging research.

[6]  James M. Allen,et al.  Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin , 2012, The Journal of cell biology.

[7]  M. Tarnopolsky,et al.  Myostatin is associated with age‐related human muscle stem cell dysfunction , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  D. Sabatini,et al.  mTOR Signaling in Growth Control and Disease , 2012, Cell.

[9]  Dudley Lamming,et al.  Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity , 2012, Science.

[10]  S. Sze,et al.  Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting. , 2011, Molecular endocrinology.

[11]  T. Koh,et al.  The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice. , 2011, Blood.

[12]  I. Ambudkar,et al.  Faculty Opinions recommendation of A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. , 2011 .

[13]  T. Reynolds,et al.  PKB signaling and atrogene expression in skeletal muscle of aged mice. , 2011, Journal of applied physiology.

[14]  V. Mootha,et al.  Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter , 2011, Nature.

[15]  Subhash D. Katewa,et al.  Role of TOR signaling in aging and related biological processes in Drosophila melanogaster , 2011, Experimental Gerontology.

[16]  C. Mammucari,et al.  Regulation of skeletal muscle growth by the IGF1-Akt/PKB pathway: insights from genetic models , 2011, Skeletal Muscle.

[17]  N. Perrimon,et al.  FOXO/4E-BP Signaling in Drosophila Muscles Regulates Organism-wide Proteostasis during Aging , 2010, Cell.

[18]  C. Kenyon.  A pathway that links reproductive status to lifespan in Caenorhabditis elegans , 2010, Annals of the New York Academy of Sciences.

[19]  Luca Scorrano,et al.  Mitochondrial fission and remodelling contributes to muscle atrophy , 2010, The EMBO journal.

[20]  C. Kenyon.  The genetics of ageing , 2010, Nature.

[21]  L. Partridge,et al.  Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogaster , 2010, Cell metabolism.

[22]  L. Schaeffer,et al.  Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy , 2009, The Journal of cell biology.

[23]  D. Metzger,et al.  Autophagy is required to maintain muscle mass. , 2009, Cell metabolism.

[24]  C. Reggiani,et al.  Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  Janet M. Thornton,et al.  Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span , 2009, Science.

[26]  Marco Pahor,et al.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.

[27]  S. Hatakeyama,et al.  Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. , 2009, American journal of physiology. Cell physiology.

[28]  C. Mammucari,et al.  Smad2 and 3 transcription factors control muscle mass in adulthood. , 2009, American journal of physiology. Cell physiology.

[29]  Emanuele Rizzuto,et al.  Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1 , 2009, Aging.

[30]  C. Reggiani,et al.  Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle. , 2008, Human molecular genetics.

[31]  Y. Nagamine.  Transcriptional regulation of the plasminogen activator inhibitor type 1 – with an emphasis on negative regulation , 2008, Thrombosis and Haemostasis.

[32]  E. Casanova,et al.  Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. , 2008, Cell metabolism.

[33]  B. Turk,et al.  AMPK phosphorylation of raptor mediates a metabolic checkpoint. , 2008, Molecular cell.

[34]  A. Goldberg,et al.  Identification of a Novel Pool of Extracellular Pro-myostatin in Skeletal Muscle* , 2008, Journal of Biological Chemistry.

[35]  N. LeBrasseur,et al.  Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. , 2008, Cell metabolism.

[36]  A. Goldberg,et al.  FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.

[37]  J. Petrella,et al.  Load-mediated downregulation of myostatin mRNA is not sufficient to promote myofiber hypertrophy in humans: a cluster analysis. , 2007, Journal of applied physiology.

[38]  P. Bénit,et al.  S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. , 2007, Cell metabolism.

[39]  S. Carr,et al.  PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. , 2007, Molecular cell.

[40]  D. Befroy,et al.  Aging-Associated Reductions in AMP-Activated Protein Kinase Activity and Mitochondrial Biogenesis , 2007, Cell metabolism.

[41]  Nicholas Ling,et al.  Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF‐κB‐independent, FoxO1‐dependent mechanism , 2006 .

[42]  Jiandie D. Lin,et al.  PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription , 2006, Proceedings of the National Academy of Sciences.

[43]  Jiandie D. Lin,et al.  Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators , 2006, Cell.

[44]  G. Vogler,et al.  Genetic determinants of weight of fast- and slow-twitch skeletal muscles in old mice , 2006, Mammalian Genome.

[45]  P. Muñoz-Cánoves,et al.  The plasminogen activation system in skeletal muscle regeneration: antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1). , 2005, Frontiers in bioscience : a journal and virtual library.

[46]  T. Koh,et al.  Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration. , 2005, American journal of physiology. Cell physiology.

[47]  J. Cross,et al.  Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women. , 2005, American journal of physiology. Endocrinology and metabolism.

[48]  G. Mcclearn,et al.  Genetic determinants of weight of fast- and slow-twitch skeletal muscle in 500-day-old mice of the C57BL/6J and DBA/2J lineage. , 2005, Physiological genomics.

[49]  N. Sonenberg,et al.  Atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control , 2005, Nature Cell Biology.

[50]  N. Rosenthal,et al.  Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle. , 2005, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[51]  D. Leroith,et al.  Skeletal muscle. , 2005, Advances in experimental medicine and biology.

[52]  G. Yancopoulos,et al.  Conditional Activation of Akt in Adult Skeletal Muscle Induces Rapid Hypertrophy , 2004, Molecular and Cellular Biology.

[53]  Se-Jin Lee.  Regulation of muscle mass by myostatin. , 2004, Annual review of cell and developmental biology.

[54]  Johan Auwerx,et al.  Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity , 2004, Nature.

[55]  I. Gout,et al.  The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins , 2004, The Journal of cell biology.

[56]  W. Fay.  Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury. , 2004, Trends in cardiovascular medicine.

[57]  R. DePinho,et al.  The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.

[58]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[59]  G. Mcclearn,et al.  Genetic architecture of fast- and slow-twitch skeletal muscle weight in 200-day-old mice of the C57BL/6J and DBA/2J lineage. , 2003, Physiological genomics.

[60]  K. Inoki,et al.  TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival , 2003, Cell.

[61]  J. Redondo,et al.  Plasminogen activator inhibitor type‐1 inhibits insulin signaling by competing with αvβ3 integrin for vitronectin binding , 2003 .

[62]  J. Redondo,et al.  Plasminogen activator inhibitor type-1 inhibits insulin signaling by competing with alphavbeta3 integrin for vitronectin binding. , 2003, European journal of biochemistry.

[63]  J. Blenis,et al.  Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. , 2002, Molecular cell.

[64]  E. Calabria,et al.  A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[65]  M. Blackman,et al.  Comparison of GH, IGF-I, and testosterone with mRNA of receptors and myostatin in skeletal muscle in older men. , 2001, American journal of physiology. Endocrinology and metabolism.

[66]  C. Rommel,et al.  Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways , 2001, Nature Cell Biology.

[67]  G. Yancopoulos,et al.  Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.

[68]  Se-Jin Lee,et al.  Regulation of myostatin activity and muscle growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Antonio Musarò,et al.  Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle , 2001, Nature Genetics.

[70]  D. Leroith,et al.  Normal growth and development in the absence of hepatic insulin-like growth factor I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[71]  J. Escalada,et al.  Growth hormone gene expression and secretion in aging rats is age dependent and not age-associated weight increase related. , 1998, Endocrinology.

[72]  Se-Jin Lee,et al.  Double muscling in cattle due to mutations in the myostatin gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[73]  S. Lamberts,et al.  The endocrinology of aging. , 1997, Science.

[74]  Se-Jin Lee,et al.  Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.

[75]  D. Loskutoff,et al.  Structural and Functional Analysis of the Plasminogen Activator Inhibitor-1 Binding Motif in the Somatomedin B Domain of Vitronectin* , 1996, The Journal of Biological Chemistry.

[76]  Roger M. Nitsch,et al.  Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion (*) , 1996, The Journal of Biological Chemistry.

[77]  E. Ruoslahti,et al.  Association of insulin receptor substrate-1 with integrins. , 1994, Science.

[78]  P. Carmeliet,et al.  Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. , 1993, The Journal of clinical investigation.

[79]  E. Pasquale,et al.  The alpha v beta 3 integrin associates with a 190-kDa protein that is phosphorylated on tyrosine in response to platelet-derived growth factor. , 1993, The Journal of biological chemistry.

[80]  M. Blackman,et al.  Human growth hormone and human aging. , 1993, Endocrine reviews.

[81]  N. Rosenthal,et al.  A transgene target for positional regulators marks early rostrocaudal specification of myogenic lineages , 1992, Cell.

[82]  L. Larsson,et al.  Effects of age on physiological, immunohistochemical and biochemical properties of fast‐twitch single motor units in the rat. , 1991, The Journal of physiology.

[83]  J. Tobin,et al.  The role of muscle loss in the age-related decline of grip strength: cross-sectional and longitudinal perspectives. , 1990, Journal of gerontology.

[84]  E. Tatum.  GENETIC DETERMINANTS , 1964 .